Multimodal multiphasic preoperative image-based deep-learning predicts HCC outcomes after curative surgery
Rex Wan-Hin Hui1, Keith Wan-Hang Chiu2, I-Cheng Lee3,4
1Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong.
A new deep-learning model, Recurr-NET, accurately predicts hepatocellular carcinoma (HCC) recurrence after surgery. This advanced tool outperforms traditional methods like microvascular invasion (MVI) assessment, offering improved preoperative prognostication for HCC patients.
Area of Science:
- Hepatocellular Carcinoma (HCC) Research
- Artificial Intelligence in Oncology
- Medical Imaging Analysis
Background:
- Hepatocellular carcinoma (HCC) recurrence is common after curative surgery.
- Histological microvascular invasion (MVI) predicts recurrence but lacks preoperative utility.
- Existing clinical prediction scores for HCC recurrence show variable performance.
Purpose of the Study:
- To develop and validate Recurr-NET, a deep-learning model for predicting HCC recurrence.
- To compare the predictive accuracy of Recurr-NET against MVI and clinical risk scores.
- To assess the potential of Recurr-NET for preoperative prognostication in HCC.
Main Methods:
- Developed Recurr-NET, a multimodal random survival forest deep-learning model.
- Incorporated preoperative CT scans and clinical parameters from HCC patients.
- Validated the model using internal (Hong Kong) and external (Taiwan) cohorts.
Main Results:
- Recurr-NET demonstrated excellent accuracy in predicting HCC recurrence from 1 to 5 years (internal AUROC 0.770-0.857, external AUROC 0.758-0.798).
- Recurr-NET significantly outperformed MVI and clinical risk scores (p < 0.001).
- The model showed superior risk stratification for recurrence and mortality compared to MVI.
Conclusions:
- Recurr-NET provides accurate preoperative prediction of HCC recurrence.
- The model surpasses MVI and clinical scores in predictive performance.
- Recurr-NET holds significant potential for improving preoperative prognostication in HCC management.
More Related Videos
07:47Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
